However, CD40 stimulation in conjunction with IL-6 inhibition and PD-1 and CTLA-4 immune checkpoint blockade did produce clinically relevant responses in syngeneic GBM models, notably the reversal of macrophage-mediated immune suppression and extended survival Yang et al., 2021. Here, CTLA4 is linked to glioblastoma.